Drugs / isosorbide di-(linoleate/oleate)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04253704 | Feb → Mar 2017 | — | Shyla Cantor | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | isosorbide di-(linoleate/oleate) | “IDL lotion is water-based (\> 80%) with isosorbide di-(linoleate/oleate) (2.0%), caprylic/capric triglycerides (5%), glycerin (3%), glyceryl stearate (2.5%), dimethicone...” NCT04253704 ↗ |
| Known as | IDL | “2% (Isosorbide di-(Linoleate/Oleate)) (IDL) Lotion” NCT04253704 ↗ |